[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
October 20, 2015

New Guidelines for Breast Cancer Screening in US Women

Author Affiliations
  • 1Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
  • 2Division of General Internal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
  • 3Division of Women’s Health, Brigham and Women’s Hospital, Boston, Massachusetts
JAMA. 2015;314(15):1569-1571. doi:10.1001/jama.2015.13086

Despite the substantial interest and investment in research on breast cancer screening, there is uncertainty about the magnitude of mammography’s benefits and harms and how to select patients and screening strategies to optimize the balance between benefits and harms. In the face of such uncertainty, thoughtful, evidence-based guidelines can play a powerful role in shaping policy and practice, supporting decision making by clinicians and patients, and identifying key research priorities. In this issue of JAMA, Oeffinger et al1 present updated breast cancer screening recommendations from the American Cancer Society (ACS), an influential voice in cancer policy and clinical care in the United States for more than 100 years.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×